FDA Approves Lilly and Incyte's OLUMIANT® (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata
"The approval of OLUMIANT can ... nausea, genital Candida infections, anemia, neutropenia, abdominal pain, herpes zoster, and weight increase. Based on animal studies, Olumiant may cause fetal ...